Patents by Inventor Dennis Alan Hanson

Dennis Alan Hanson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6485928
    Abstract: The T cell activation marker, granulysin, is demonstrated to be an effective antimicrobial agent. It is used in vitro and in vivo to reduce the population of viable cells in a microbial population. Of particular interest is the use of the active fragment of human granulysin, or modified forms thereof, to treat bacterial infections.
    Type: Grant
    Filed: November 3, 1998
    Date of Patent: November 26, 2002
    Assignees: The Board of Trustees of the Leland Stanford Junior University, The Regents of the University of California
    Inventors: Steffen Stenger, Robert L. Modlin, Dennis Alan Hanson, Alan M. Krensky
  • Publication number: 20020044927
    Abstract: The T cell activation marker, granulysin, is demonstrated to be an effective antimicrobial agent. It is used in vitro and in vivo to reduce the population of viable cells in a microbial population. Of particular interest is the use of the active fragment of human granulysin, or modified forms thereof, to treat bacterial infections.
    Type: Application
    Filed: November 3, 1998
    Publication date: April 18, 2002
    Applicant: BOZICEVIC, FIELD AND FRANCIS LLP
    Inventors: STEFFEN STENGER, ROBERT L. MODLIN, DENNIS ALAN HANSON, ALAN M. KRENSKY